Physician profile
Gary Schmidt
NPI 1922041128
$255,806.60
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,954 · 2020: $1,775 · 2021: $946 · 2022: $132 · 2023: $250K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philadelphia Medical Management Company LLC | $250,000.00 | 2023 | |
| The Institute of Musculoskeletal Science and Education | $3,151.77 | 2019-2020 | |
| Medtronic USA, INC. | $1,160.44 | 2019-2020 | |
| Camber Spine Technologies LLC | $730.22 | 2019-2021 | |
| Stryker Corporation | $291.74 | 2019-2022 | |
| Abbott Laboratories | $181.39 | 2019 | |
| Next Science LLC | $115.10 | 2021 | |
| Depuy Synthes Sales INC. | $76.32 | 2019 | |
| Bioventus LLC | $52.00 | 2019 | |
| Pacira Therapeutics, INC. | $25.91 | 2021 | |
| Innovation Technologies INC | $21.71 | 2020 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,000,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.